Form 8-K - Current report:
SEC Accession No. 0001104659-26-094041
Filing Date
2026-08-11
Accepted
2026-08-11 16:05:23
Documents
14
Period of Report
2026-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20260811x8k.htm   iXBRL 8-K 29049
2 EX-99.1 ganx-20260811xex99d1.htm EX-99.1 191606
3 GRAPHIC ganx-20260811xex99d1001.jpg GRAPHIC 3662
  Complete submission text file 0001104659-26-094041.txt   362877

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20260811.xsd EX-101.SCH 3377
5 EX-101.DEF ganx-20260811_def.xml EX-101.DEF 2826
6 EX-101.LAB ganx-20260811_lab.xml EX-101.LAB 17907
7 EX-101.PRE ganx-20260811_pre.xml EX-101.PRE 10618
17 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20260811x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 261263124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)